TARA DEBOER, PhD
CO-FOUNDER and CTO
Dr. deBoer received her PhD from the University of California, Santa Cruz in June of 2015. Her thesis work focused on the synthesis of metal-based therapeutics and the design of modular systems to explore the biochemistry of reactive nitrogen and oxygen species. After receiving her doctorate degree she began her postdoctoral work in Prof. Niren Murthy’s group where she currently works on applied projects aimed at developing diagnostic options capable of detecting antibacterial resistance and designing innovative tools that can be utilized to explore the cleavage activity of one of the CRISPR-associated proteins Cas9.